These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18454571)

  • 1. Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.
    Uppal NK; Dupuis LL; Parshuram CS
    Paediatr Drugs; 2008; 10(3):193-7. PubMed ID: 18454571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric drug data in Canadian drug monographs: a descriptive analysis.
    Raja P; Duffett M; Mazer-Amirshahi M; Patel A; Gilpin A; Litalien C; Chan AK; van den Anker J; Lacaze-Masmonteil T; Samiee-Zafarghandy S
    CMAJ Open; 2020; 8(3):E522-E529. PubMed ID: 32873580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of Canadian general pediatric dosing publications.
    Dayneka N
    Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.
    Nguyen CT; MacEntee MI; Mintzes B; Perry TL
    Drugs Aging; 2014 Jan; 31(1):55-65. PubMed ID: 24293180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents against pediatric diarrhea. Assessing the information companies supply to Canadian physicians.
    Lexchin J
    Can Fam Physician; 1994 Dec; 40():2082-7. PubMed ID: 7888820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration guidelines for parenteral drug therapy. Part I: Pediatric patients.
    Klaus JR; Knodel LC; Kavanagh RE
    J Pharm Technol; 1989; 5(3):101-28. PubMed ID: 10318297
    [No Abstract]   [Full Text] [Related]  

  • 7. Salty broth for salicylate poisoning? Adequacy of overdose management advice in the 2001 Compendium of Pharmaceuticals and Specialties.
    Brubacher JR; Purssell R; Kent DA
    CMAJ; 2002 Oct; 167(9):992-6. PubMed ID: 12403737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Compendium of Pharmaceuticals and Specialties: a critical analysis.
    Bell RW; Osterman JW
    Int J Health Serv; 1983; 13(1):107-18. PubMed ID: 6832868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to home.
    Lee BH; Lehmann CU; Jackson EV; Kost-Byerly S; Rothman S; Kozlowski L; Miller MR; Pronovost PJ; Yaster M
    J Pain; 2009 Feb; 10(2):160-6. PubMed ID: 19010736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.
    Roberts R; Rodriguez W; Murphy D; Crescenzi T
    JAMA; 2003 Aug; 290(7):905-11. PubMed ID: 12928467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.
    Korenstein D; Keyhani S; Mendelson A; Ross JS
    PLoS One; 2011; 6(8):e23336. PubMed ID: 21858076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive List of Items to be Included on a Pediatric Drug Monograph.
    Kelly LE; Ito S; Woods D; Nunn AJ; Taketomo C; de Hoog M; Offringa M
    J Pediatr Pharmacol Ther; 2017; 22(1):48-59. PubMed ID: 28337081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug prescription for hospitalized pediatric patients: how can the quality be evaluated?].
    Meiners MM; Bergsten-Mendes G
    Rev Assoc Med Bras (1992); 2001; 47(4):332-7. PubMed ID: 11813049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prescription of drugs not appropriate for children in a Pediatric Intensive Care Unit].
    Carvalho PR; Carvalho CG; Alievi PT; Martinbiancho J; Trotta EA
    J Pediatr (Rio J); 2003; 79(5):397-402. PubMed ID: 14557839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misleading score-lines on tablets: facilitated intake or fractional dosing?
    Arnet I; Hersberger KE
    Swiss Med Wkly; 2010 Feb; 140(7-8):105-10. PubMed ID: 20069474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug related problems and off-label drug treatment in children as seen at a drug information centre.
    Kimland E; Bergman U; Lindemalm S; Böttiger Y
    Eur J Pediatr; 2007 Jun; 166(6):527-32. PubMed ID: 17195069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug prescribing. Licensing flaws.
    Watts G
    Health Serv J; 1999 Jan; 109(5639):suppl 9-11. PubMed ID: 10345648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.